Pioneer Surgical Technology, Inc. Names Thomas J. McLeer as Chief Marketing Officer and General Manager of Spinal Operations
Posted on: Friday, 10 July 2009, 13:30 CDT
Mr. McLeer, who had been Vice President of Sales & Marketing at Archus Orthopedics, will be in charge of managing and directing all of Pioneer's spinal operations, including marketing and sales.
"Tom brings real world spine experience to a high class organization," noted
Before joining Pioneer Surgical Technology, Inc., Mr. McLeer was responsible for directing all aspects of the creation of a new spinal implant segment at Archus Orthopedics, including world-wide strategy, growth, and development. He developed marketing, distribution, and training to facilitate clinical efforts and established local representation to handle cases in
Prior to Archus Orthopedics, Mr. McLeer held the role of Vice President of Business Development at Spinal Concepts, Inc. Previous to that he served as Vice President of Marketing at Interpore Cross, Inc., and in various product management roles at Zimmer, Inc. He also gained market experience serving in sales representative roles at Intermedics Associates, Inc., Howmedica-Johnson, Inc., and Abbott Laboratories early in his career.
Mr. McLeer has also been named inventor on numerous issued or pending medical device patents. Mr. McLeer holds a B.S. in Business Administration and Marketing from
About Pioneer Surgical Technology, Inc.
Pioneer Surgical Technology, Inc. is a dynamic medical device firm headquartered in
SOURCE Pioneer Surgical Technology, Inc.
Source: PR Newswire
Related Articles
- Cardium Announces Conference Call and Webcast to Review Recent Developments and Future Plans for the Excellarate(TM) Clinical Development Program
- PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
- Repros Therapeutics Inc. Reports First Quarter 2008 Financial Results and Provides Clinical Development Program Overview
- Tranzyme Pharma Strengthens Clinical Development Team With the Appointment of Philippa A. Charlton, MD, MPH As Medical Director
- Phase II Results for CDP791 in Non-Small Cell Lung Cancer Support Further Clinical Development
- Repros Therapeutics Inc. Reports Fourth Quarter and Year End 2007 Financial Results and Provides Clinical Development Program Overview
- DOR BioPharma Announces Initiation of Clinical Development Program for Oral Leuprolide
- Idera Pharmaceuticals Appoints Dr. Alice Bexon, Vice President of Clinical Development
- Paul Strauss, M.D. Joins Omeros As VP, Clinical Development
- MorphoSys Strengthens Pre-Clinical Development and Finance Departments in New Management Positions
User Comments (0)

RSS Feeds